Silver dressing in the treatment of diabetic foot:A protocol for systematic review and meta-analysis

Chunhua Huang, Ruiqi Wang, Zhangren Yan2021 · DOI

This document outlines a formal protocol for a systematic review and meta-analysis. It serves as a roadmap for researchers to evaluate the clinical effectiveness of silver-based dressings in treating diabetic foot ulcers.

TL;DR

This protocol establishes a rigorous framework for a systematic review and meta-analysis to determine if silver dressings improve healing outcomes for diabetic foot ulcers compared to standard treatments. By synthesizing data from randomized controlled trials (RCTs), the authors aim to provide high-level evidence to guide clinical decision-making for a condition that currently drives 70% of amputations worldwide.

What Problem Does This Paper Address?

Diabetic Foot (DF) is a severe chronic complication of diabetes, characterized by infection, ulceration, and deep tissue destruction. It is a leading cause of disability and death among diabetic patients, with a global prevalence rate of 4–10%. The stakes are incredibly high: infection often leads to amputation, and post-amputation mortality rates are significant.

While silver is well-known in the medical community for its antimicrobial properties, its actual efficacy in dressing diabetic wounds—compared to cheaper or traditional alternatives like saline gauze or foam—is a subject of ongoing debate. Clinicians need to know if the added cost of silver dressings translates into faster healing or lower amputation rates. This paper addresses the lack of a consolidated, high-evidence-level answer by proposing a standardized method to analyze existing research.

Methods

The authors propose a systematic review of Randomized Controlled Trials (RCTs), which are considered the gold standard for clinical evidence. Their approach includes:

  • Search Strategy: A comprehensive search of both Western and Chinese databases (including PubMed, Embase, Cochrane Library, CNKI, and Wanfang) for studies published up to January 2021.
  • Selection Criteria: The review will only include RCTs involving patients diagnosed with DF. The experimental group must use silver ion dressings, while the control group uses other dressings (e.g., saline gauze, alginate, or foam).
  • Data Synthesis: Researchers will use Reviewer Manager 5.3 software. They will calculate Mean Difference (MD) for continuous data (like healing time) and Odds Ratio (OR) for categorical data (like healing rate).
  • Statistical Rigor: The protocol includes plans for assessing heterogeneity (using the $I^2$ statistic) and publication bias (using funnel plots). If significant heterogeneity is found, they will employ a random-effects model and perform subgroup analyses based on factors like treatment duration or patient age.

Datasets

As this is a protocol for a meta-analysis, the "data" consists of primary research studies rather than a raw dataset. The authors will aggregate results from:

  • International Databases: PubMed, Embase, Cochrane Library.
  • Chinese Databases: China Knowledge Network (CNKI), SinoMed, VIP Database, and Wanfang Database.

The inclusion of major Chinese databases is a notable strength, as it captures a significant volume of clinical research that is often omitted from Western-centric meta-analyses.

Key Insights and Ideas

  • Focus on Physiological Milestones: Rather than just looking at a binary "healed/not healed" outcome, the protocol tracks specific milestones: granulation tissue appearance time and epithelial formation time. This provides a more granular look at how the wound is healing.
  • Rigorous Exclusion: To ensure the data isn't skewed, the authors will exclude participants with "serious underlying diseases," focusing the results on the efficacy of the dressing itself rather than the patient's overall systemic health failures.
  • Addressing Bias: The protocol mandates that two researchers independently screen the literature, with a third-party personnel to resolve inconsistencies, minimizing subjective bias in study selection.

Key Results

As this document is a study protocol, quantitative results are not yet available. The intended result of the future study will be a definitive statistical comparison showing whether silver dressings provide a statistically significant advantage in wound healing rates and times over other common dressing types.

Limitations and Future Work

  • Garbage In, Garbage Out: The final meta-analysis will only be as strong as the RCTs it includes. If the underlying studies have small sample sizes or poor blinding, the conclusions will be limited.
  • Dressing Diversity: "Silver dressing" is a broad category. Different brands and delivery mechanisms (ions vs. nanocrystalline silver) may perform differently. While the authors plan subgroup analyses, the inherent variety in medical products may introduce "clinical heterogeneity."
  • Language and Geographic Bias: While the search includes major English and Chinese databases, it may miss relevant trials published in other languages (e.g., Spanish or German), which could limit the global generalizability of the findings.

Summary updated

Abstract

Review question / Objective: To search for relevant studies on the treatment of DF with silver dressings through evidencebased medicine methods and to draw conclusions with higher levels of evidence to provide a basis for the clinical treatment of DF.Condition being studied: Diabetic foot (DF) is the most serious and common chronic complication of elderly patients with diabetes and in severe cases, the infection can lead to amputation or even death.It is mainly caused by foot (ankle joint or below) infection, ulcer, and (or) deep tissue destruction related to abnormalities of the distal nerves of the lower extremities and various degrees of peripheral vascular disease.Its main clinical manifestations are foot ulcers and gangrene, which are one of the main causes of amputation and disability in diabetic patients.These complications include infection and lower extremity amputation, which have become one of the major causes of disability and death among diabetes patients.With a prevalence rate of 4-10%, amputation is needed to control the infection to save the lives of patients.70% of amputations worldwide occur in people with diabetic feet and die after amputation.DF not only affects the physical health of patients but also causes patients to produce anxiety and depression and other unhealthy emotions, bringing a heavy economic burden to the family and society.
BibTeX
@misc{huang2021silver,
  author = {Chunhua Huang and Ruiqi Wang and Zhangren Yan},
  title = {{Silver dressing in the treatment of diabetic foot:A protocol for systematic review and meta-analysis}},
  year = {2021},
  doi = {10.37766/inplasy2021.1.0112},
}
Figure